Impaired adenosine-mediated angiogenesis in preeclampsia: Potential implications for fetal programming

Frontiers in Pharmacology

Volumn 5 JUN, Issue , 2014, Pages

  Escudero, Carlos ^a   Roberts, James M ^b   Myatt, Leslie ^c   Feoktistov, Igor ^d,e  

^a UNIVERSIDAD DEL BÍO BÍO   (Chile)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine receptors; Angiogenesis; Placenta; Preeclampsia; Programming

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR;

ADVERSE OUTCOME; BLOOD FLOW; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FETAL PROGRAMMING; FETUS DEVELOPMENT; FETUS GROWTH; HUMAN; HYPERTENSION; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PREECLAMPSIA; PROGENY; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84904731742     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00134     Document Type: Review

References (144)

1. ACOG, Task Force of Hypertension in Pregnancy. (2013). Hypertension in Pregnancy. Washington. American College of Obstetrician and Gynecologists.
2. Acurio, J., Troncoso, F., Bertoglia, P., Salomon, C., Aguayo, C., Sobrevia, L., et al. (2014). Potential role of A2B adenosine receptors on proliferation/migration of fetal endothelium derived from pre-eclamptic pregnancies. BioMed Res. Int. 2014:274507. doi: 10.1155/2014/274507.
3. Afzal, A., Shaw, L. C., Caballero, S., Spoerri, P. E., Lewin, A. S., Zeng, D., et al. (2003). Reduction in preretinal neovascularization by ribozymes that cleave the A2B adenosine receptor mRNA. Circ. Res. 93, 500-506. doi: 10.1161/01.RES.0000091260.78959.BC.
4. Ahmad, A., Ahmad, S., Glover, L., Miller, S. M., Shannon, J. M., Guo, X., et al. (2009). Adenosine A2A receptor is a unique angiogenic target of HIF-2alpha in pulmonary endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 106, 10684-10689. doi: 10.1073/pnas.0901326106.
5. Andraweera, P. H., Dekker, G. A., Laurence, J. A., and Roberts, C. T. (2012). Placental expression of VEGF family mRNA in adverse pregnancy outcomes. Placenta 33, 467-472. doi: 10.1016/j.placenta.2012.02.013.
6. Belfort, M. B., Gillman, M. W., and Mccormick, M. C. (2012). Prenatal and perinatal predictors of blood pressure at school age in former preterm, low birth weight infants. J. Perinatol. 32, 265-269. doi: 10.1038/jp.2011.88.
7. Brown, S. T., Reyes, E. P., and Nurse, C. A. (2011). Chronic hypoxia upregulates adenosine 2A receptor expression in chromaffin cells via hypoxia inducible factor-2alpha: role in modulating secretion. Biochem. Biophys. Res. Commun. 412, 466-472. doi: 10.1016/j.bbrc.2011.07.122.
8. Brunner, H., Cockcroft, J. R., Deanfield, J., Donald, A., Ferrannini, E., Halcox, J., et al. (2005). Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J. Hypertens. 23, 233-246. doi: 10.1097/00004872-200502000-00001.
9. Bshesh, K., Zhao, B., Spight, D., Biaggioni, I., Feokistov, I., Denenberg, A., et al. (2002). The A2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells. J. Leukoc. Biol. 72, 1027-1036..
10. Burton, G. J., Charnock-Jones, D. S., and Jauniaux, E. (2009a). Regulation of vascular growth and function in the human placenta. Reproduction 138, 895-902. doi: 10.1530/REP-09-0092.
11. Burton, G. J., Woods, A. W., Jauniaux, E., and Kingdom, J. C. (2009b). Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 30, 473-482. doi: 10.1016/j.placenta.2009.02.009.
12. Byers, B. D., Betancourt, A., Lu, F., Hankins, G. D., Longo, M., Saade, G. R., et al. (2009). The effect of prepregnancy obesity and sFlt-1-induced preeclampsia-like syndrome on fetal programming of adult vascular function in a mouse model. Am. J. Obstet. Gynecol. 200, 432.e431-e437. doi: 10.1016/j.ajog.2009.01.044.
13. Bytautiene, E., Tamayo, E., Kechichian, T., Drever, N., Gamble, P., Hankins, G. D., et al. (2011). Prepregnancy obesity and sFlt1-induced preeclampsia in mice: developmental programming model of metabolic syndrome. Am. J. Obstet. Gynecol. 204, 398.e1-398.e8. doi: 10.1016/j.ajog.2011.02.031.
14. Casanello, P., Escudero, C., and Sobrevia, L. (2007). Equilibrative nucleoside (ENTs) and cationic amino acid (CATs) transporters: implications in foetal endothelial dysfunction in human pregnancy diseases. Curr. Vasc. Pharmacol. 5, 69-84. doi: 10.2174/157016107779317198.
15. Chen, X., and Wang, Y. (2008). Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis. Circulation 117, 3171-3180. doi: 10.1161/CIRCULATIONAHA.107.730366.
16. Cheng, S. W., Chou, H. C., Tsou, K. I., Fang, L. J., and Tsao, P. N. (2004). Delivery before 32 weeks of gestation for maternal pre-eclampsia: neonatal outcome and 2-year developmental outcome. Early Hum. Dev. 76, 39-46. doi: 10.1016/j.earlhumdev.2003.10.004.
17. Clark, A. N., Youkey, R., Liu, X., Jia, L., Blatt, R., Day, Y. J., et al. (2007). A1 adenosine receptor activation promotes angiogenesis and release of VEGF from monocytes. Circ. Res. 101, 1130-1138. doi: 10.1161/CIRCRESAHA.107.150110.
18. Coney, A. M., and Marshall, J. M. (2010). Effects of maternal hypoxia on muscle vasodilatation evoked by acute systemic hypoxia in adult rat offspring: changed roles of adenosine and A1 receptors. J. Physiol. 588, 5115-5125. doi: 10.1113/jphysiol.2010.198275.
19. Davis, E. F., Lazdam, M., Lewandowski, A. J., Worton, S. A., Kelly, B., Kenworthy, Y., et al. (2012a). Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics 129, e1552-e1561. doi: 10.1542/peds.2011-3093.
20. Davis, E. F., Newton, L., Lewandowski, A. J., Lazdam, M., Kelly, B. A., Kyriakou, T., et al. (2012b). Pre-eclampsia and offspring cardiovascular health: mechanistic insights from experimental studies. Clin. Sci. 123, 53-72. doi: 10.1042/CS20110627.
21. Desai, A., Victor-Vega, C., Gadangi, S., Montesinos, M. C., Chu, C. C., and Cronstein, B. N. (2005). Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1. Mol. Pharmacol. 67, 1406-1413. doi: 10.1124/mol.104.007807.
22. Dubey, R. K., Gillespie, D. G., and Jackson, E. K. (2002). A(2B) adenosine receptors stimulate growth of porcine and rat arterial endothelial cells. Hypertension 39, 530-535. doi: 10.1161/hy0202.103075.
23. Duley, L. (2009). The global impact of pre-eclampsia and eclampsia. Semin. Perinatol. 33, 130-137. doi: 10.1053/j.semperi.2009.02.010.
24. Dye, J., Lawrence, L., Linge, C., Leach, L., Firth, J., and Clark, P. (2004). Distinct patterns of microvascular endothelial cell morphology are determined by extracellular matrix composition. Endothelium 11, 151-167. doi: 10.1080/10623320490512093.
25. Eckle, T., Krahn, T., Grenz, A., Kohler, D., Mittelbronn, M., Ledent, C., et al. (2007). Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115, 1581-1590. doi: 10.1161/CIRCULATIONAHA.106.669697.
26. Eltzschig, H. K., Ibla, J. C., Furuta, G. T., Leonard, M. O., Jacobson, K. A., Enjyoji, K., et al. (2003). Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J. Exp. Med. 198, 783-796. doi: 10.1084/jem.20030891.
27. Ernens, I., Leonard, F., Vausort, M., Rolland-Turner, M., Devaux, Y., and Wagner, D. R. (2010). Adenosine up-regulates vascular endothelial growth factor in human macrophages. Biochem. Biophys. Res. Commun. 392, 351-356. doi: 10.1016/j.bbrc.2010.01.023.
28. Escudero, C., Bertoglia, P., Hernadez, M., Celis, C., Gonzalez, M., Aguayo, C., et al. (2012). Impaired A(2A) adenosine receptor/nitric oxide/VEGF signaling pathway in fetal endothelium during late- and early-onset preeclampsia. Purinergic Signal. doi: 10.1007/s11302-012-9341-4.
29. Escudero, C., Casanello, P., and Sobrevia, L. (2008). Human equilibrative nucleoside transporters 1 and 2 may be differentially modulated by A2B adenosine receptors in placenta microvascular endothelial cells from pre-eclampsia. Placenta 29, 816-825. doi: 10.1016/j.placenta.2008.06.014.
30. Escudero, C., Celis, C., Saez, T., San Martin, S., Valenzuela, F. J., Aguayo, C., et al. (2014). Increased placental angiogenesis in late and early onset pre-eclampsia is associated with differential activation of vascular endothelial growth factor receptor 2. Placenta 35, 207-215. doi: 10.1016/j.placenta.2014.01.007.
31. Escudero, C., Puebla, C., Westermeier, F., and Sobrevia, L. (2009). Potential cell signalling mechanisms involved in differential placental angiogenesis in mild and severe pre-eclampsia. Curr. Vasc. Pharmacol. 7, 475-485. doi: 10.2174/157016109789043865.
32. Escudero, C., and Sobrevia, L. (2008). A hypothesis for preeclampsia: adenosine and inducible nitric oxide synthase in human placental microvascular endothelium. Placenta 29, 469-483. doi: 10.1016/j.placenta.2008.02.008.
33. Escudero, C., and Sobrevia, L. (2009). "Understanding physiological significance of high extracellular adenosine levels in feto-placental circulation in preeclamptic pregnancies," in Membrane Transporters and Receptors in Disease, eds L. Sobrevia and P. Casanello (Kerala, India: Research Signpost), 27-51.
34. Escudero, C., and Sobrevia, L. (2012). Adenosine plasma levels in the fetoplacental circulation in preeclampsia. Am. J. Obstet. Gynecol. 206, e5-e6. doi: 10.1016/j.ajog.2011.12.032.
35. Espinoza, J., Espinoza, A. F., and Power, G. G. (2011). High fetal plasma adenosine concentration: a role for the fetus in preeclampsia? Am. J. Obstet. Gynecol. 205, 485.e24-485.e27. doi: 10.1016/j.ajog.2011.06.034.
36. Fang, Y., and Olah, M. E. (2007). Cyclic AMP-dependent, protein kinase A-independent activation of extracellular signal-regulated kinase 1/2 following adenosine receptor stimulation in human umbilical vein endothelial cells: role of exchange protein activated by cAMP 1 (Epac1). J. Pharmacol. Exp. Ther. 322, 1189-1200. doi: 10.1124/jpet.107.119933.
37. Feoktistov, I., and Biaggioni, I. (1995). Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J. Clin. Invest. 96, 1979-1986. doi: 10.1172/JCI118245.
38. Feoktistov, I., Goldstein, A. E., Ryzhov, S., Zeng, D., Belardinelli, L., Voyno-Yasenetskaya, T., et al. (2002). Differential expression of adenosine receptors in human endothelial cells: role of A2B receptors in angiogenic factor regulation. Circ. Res. 90, 531-538. doi: 10.1161/01.RES.0000012203.21416.14.
39. Feoktistov, I., Ryzhov, S., Goldstein, A. E., and Biaggioni, I. (2003). Mast cell-mediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors. Circ. Res. 92, 485-492. doi: 10.1161/01.RES.0000061572.10929.2D.
40. Feoktistov, I., Ryzhov, S., Zhong, H., Goldstein, A. E., Matafonov, A., Zeng, D., et al. (2004). Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype. Hypertension 44, 649-654. doi: 10.1161/01.HYP.0000144800.21037.a5.
41. Gellhaus, A., Schmidt, M., Dunk, C., Lye, S. J., Kimmig, R., and Winterhager, E. (2006). Decreased expression of the angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associated with pre-eclampsia. Mol. Hum. Reprod. 12, 389-399. doi: 10.1093/molehr/gal044.
42. George, E. M., Cockrell, K., Adair, T. H., and Granger, J. P. (2010). Regulation of sFlt-1 and VEGF secretion by adenosine under hypoxic conditions in rat placental villous explants. Am. J. Physiol. Regul. Integr. Comp. Physiol. 299, R1629-R1633. doi: 10.1152/ajpregu.00330.2010.
43. Gessi, S., Fogli, E., Sacchetto, V., Merighi, S., Varani, K., Preti, D., et al. (2010). Adenosine modulates HIF-1{alpha}, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells. Arterioscler. Thromb. Vasc. Biol. 30, 90-97. doi: 10.1161/ATVBAHA.109.194902.
44. Glover, V. (2011). Annual research review: prenatal stress and the origins of psychopathology: an evolutionary perspective. J. Child Psychol. Psychiatry 52, 356-367. doi: 10.1111/j.1469-7610.2011.02371.x.
45. Gluckman, P. D., and Hanson, M. A. (2004). Living with the past: evolution, development, and patterns of disease. Science 305, 1733-1736. doi: 10.1126/science.1095292.
46. Grant, M. B., Davis, M. I., Caballero, S., Feoktistov, I., Biaggioni, I., and Belardinelli, L. (2001). Proliferation, migration, and ERK activation in human retinal endothelial cells through A(2B) adenosine receptor stimulation. Invest. Ophthalmol. Vis. Sci. 42, 2068-2073..
47. Grant, M. B., Tarnuzzer, R. W., Caballero, S., Ozeck, M. J., Davis, M. I., Spoerri, P. E., et al. (1999). Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. Circ. Res. 85, 699-706. doi: 10.1161/01.RES.85.8.699.
48. Greene, J. M., Dunaway, C. W., Bowers, S. D., Rude, B. J., Feugang, J. M., and Ryan, P. L. (2011). In vivo monitoring of fetoplacental Vegfr2 gene activity in a murine pregnancy model using a Vegfr2-luc reporter gene and bioluminescent imaging. Reprod. Biol. Endocrinol. 51. doi: 10.1186/1477-7827-9-51.
49. Griffith, M. I., Mann, J. R., and Mcdermott, S. (2011). The risk of intellectual disability in children born to mothers with preeclampsia or eclampsia with partial mediation by low birth weight. Hypertens. Pregnancy 30, 108-115. doi: 10.3109/10641955.2010.507837.
50. Hanson, M. A., and Gluckman, P. D. (2008). Developmental origins of health and disease: new insights. Basic Clin. Pharmacol. Toxicol. 102, 90-93. doi: 10.1111/j.1742-7843.2007.00186.x.
51. Harb, R., Whiteus, C., Freitas, C., and Grutzendler, J. (2013). In vivo imaging of cerebral microvascular plasticity from birth to death. J. Cereb. Blood Flow Metab. 33, 146-156. doi: 10.1038/jcbfm.2012.152.
52. Headrick, J. P., Ashton, K. J., Rose'meyer, R. B., and Peart, J. N. (2013). Cardiovascular adenosine receptors: expression, actions and interactions. Pharmacol. Ther. doi: 10.1016/j.pharmthera.2013.06.002.
53. Hiller, J. E., Crowther, C. A., Moore, V. A., Willson, K., and Robinson, J. S. (2007). Calcium supplementation in pregnancy and its impact on blood pressure in children and women: follow up of a randomised controlled trial. Aust. N. Z. J. Obstet. Gynaecol. 47, 115-121. doi: 10.1111/j.1479-828X.2007.00696.x.
54. Jacobson, K. A., and Gao, Z. G. (2006). Adenosine receptors as therapeutic targets. Nat. Rev. Drug Discov. 5, 247-264. doi: 10.1038/nrd1983.
55. Jayet, P. Y., Rimoldi, S. F., Stuber, T., Salmon, C. S., Hutter, D., Rexhaj, E., et al. (2010). Pulmonary and systemic vascular dysfunction in young offspring of mothers with preeclampsia. Circulation 122, 488-494. doi: 10.1161/CIRCULATIONAHA.110.941203.
56. Junus, K., Centlow, M., Wikstrom, A. K., Larsson, I., Hansson, S. R., and Olovsson, M. (2012). Gene expression profiling of placentae from women with early- and late-onset pre-eclampsia: down-regulation of the angiogenesis-related genes ACVRL1 and EGFL7 in early-onset disease. Mol. Hum. Reprod. 18, 146-155. doi: 10.1093/molehr/gar067.
57. Kafkasli, A., Karabulut, A. B., Atmaca, R., and Laurini, R. (2006). Clinical correlation between adenosine deaminase activity and pre-eclampsia severity. J. Int. Med. Res. 34, 247-255. doi: 10.1177/147323000603400303.
58. Kajantie, E., Eriksson, J. G., Osmond, C., Thornburg, K., and Barker, D. J. (2009). Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke 40, 1176-1180. doi: 10.1161/STROKEAHA.108.538025.
59. Kim, G. D., Oh, J., Jeong, L. S., and Lee, S. K. (2013). Thio-Cl-IB-MECA, a novel A(3) adenosine receptor agonist, suppresses angiogenesis by regulating PI3K/AKT/mTOR and ERK signaling in endothelial cells. Biochem. Biophys. Res. Commun. 437, 79-86. doi: 10.1016/j.bbrc.2013.06.040.
60. Kim, S. C., Park, M. J., Joo, B. S., Joo, J. K., Suh, D. S., and Lee, K. S. (2012). Decreased expressions of vascular endothelial growth factor and visfatin in the placental bed of pregnancies complicated by preeclampsia. J. Obstet. Gynaecol. Res. 38, 665-673. doi: 10.1111/j.1447-0756.2011.01773.x.
61. Kim, Y. H., Hwang, H. S., Kim, Y. T., Kim, H. S., and Park, Y. W. (2008). Modulation of matrix metalloproteinase secretion by adenosine A3 receptor in preeclamptic villous explants. Reprod. Sci. 15, 939-949. doi: 10.1177/1933719108322431.
62. Kimura, H., Ogura, T., Kurashima, Y., Weisz, A., and Esumi, H. (2002). Effects of nitric oxide donors on vascular endothelial growth factor gene induction. Biochem. Biophys. Res. Commun. 296, 976-982. doi: 10.1016/S0006-291X(02)02029-6.
63. Kimura, H., Weisz, A., Kurashima, Y., Hashimoto, K., Ogura, T., D'acquisto, F., et al. (2000). Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95, 189-197..
64. Kong, T., Westerman, K. A., Faigle, M., Eltzschig, H. K., and Colgan, S. P. (2006). HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J. 20, 2242-2250. doi: 10.1096/fj.06-6419com.
65. Krause, B., Sobrevia, L., and Casanello, P. (2009). Epigenetics: new concepts of old phenomena in vascular physiology. Curr. Vasc. Pharmacol. 7, 513-520. doi: 10.2174/157016109789043883.
66. Kvehaugen, A. S., Andersen, L. F., and Staff, A. C. (2010). Anthropometry and cardiovascular risk factors in women and offspring after pregnancies complicated by preeclampsia or diabetes mellitus. Acta Obstet. Gynecol. Scand. 89, 1478-1485. doi: 10.3109/00016349.2010.500368.
67. Kvehaugen, A. S., Dechend, R., Ramstad, H. B., Troisi, R., Fugelseth, D., and Staff, A. C. (2011). Endothelial function and circulating biomarkers are disturbed in women and children after preeclampsia. Hypertension 58, 63-69. doi: 10.1161/HYPERTENSIONAHA.111.172387.
68. Kwon, J. Y., Maeng, Y. S., Kwon, Y. G., Kim, Y. H., Kang, M. H., and Park, Y. W. (2007). Decreased endothelial progenitor cells in umbilical cord blood in severe preeclampsia. Gynecol. Obstet. Invest. 64, 103-108. doi: 10.1159/000100081.
69. Lankhorst, S., Kappers, M. H., Van Esch, J. H., Danser, A. H., and Van Den Meiracker, A. H. (2013). Hypertension during vascular endothelial growth factor inhibition: focus on nitric oxide, endothelin-1, and oxidative stress. Antioxid. Redox Signal. doi: 10.1089/ars.2013.5244.
70. Lawlor, D. A., Macdonald-Wallis, C., Fraser, A., Nelson, S. M., Hingorani, A., Davey Smith, G., et al. (2012). Cardiovascular biomarkers and vascular function during childhood in the offspring of mothers with hypertensive disorders of pregnancy: findings from the Avon Longitudinal Study of Parents and Children. Eur. Heart J. 33, 335-345. doi: 10.1093/eurheartj/ehr300.
71. Lazdam, M., De La Horra, A., Pitcher, A., Mannie, Z., Diesch, J., Trevitt, C., et al. (2010). Elevated blood pressure in offspring born premature to hypertensive pregnancy: is endothelial dysfunction the underlying vascular mechanism? Hypertension 56, 159-165. doi: 10.1161/HYPERTENSIONAHA.110.150235.
72. Lee, S. J., Hwang, H. S., Kim, B. N., Kim, M. A., Lee, J. W., Park, Y. W., et al. (2007). Changes in serum adenosine deaminase activity during normal pregnancy. J. Korean Med. Sci. 22, 718-721. doi: 10.3346/jkms.2007.22.4.718.
73. Leibovich, S. J., Chen, J. F., Pinhal-Enfield, G., Belem, P. C., Elson, G., Rosania, A., et al. (2002). Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin. Am. J. Pathol. 160, 2231-2244. doi: 10.1016/S0002-9440(10)61170-4.
74. Lennon, P. F., Taylor, C. T., Stahl, G. L., and Colgan, S. P. (1998). Neutrophil-derived 5'-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation. J. Exp. Med. 188, 1433-1443. doi: 10.1084/jem.188.8.1433.
75. Leonard, F., Devaux, Y., Vausort, M., Ernens, I., Rolland-Turner, M., and Wagner, D. R. (2011). Adenosine modifies the balance between membrane and soluble forms of Flt-1. J. Leukoc. Biol. 90, 199-204. doi: 10.1189/jlb.0910505.
76. Letourneur, A., Freret, T., Roussel, S., Boulouard, M., Divoux, D., Toutain, J., et al. (2012). Maternal hypertension during pregnancy modifies the response of the immature brain to hypoxia-ischemia: sequential MRI and behavioral investigations. Exp. Neurol. 233, 264-272. doi: 10.1016/j.expneurol.2011.10.014.
77. Li, J., Fenton, R. A., Wheeler, H. B., Powell, C. C., Peyton, B. D., Cutler, B. S., et al. (1998). Adenosine A2a receptors increase arterial endothelial cell nitric oxide. J. Surg. Res. 80, 357-364. doi: 10.1006/jsre.1998.5439.
78. Loffler, M., Morote-Garcia, J. C., Eltzschig, S. A., Coe, I. R., and Eltzschig, H. K. (2007). Physiological roles of vascular nucleoside transporters. Arterioscler. Thromb. Vasc. Biol. 27, 1004-1013. doi: 10.1161/ATVBAHA.106.126714.
79. Lu, F., Bytautiene, E., Tamayo, E., Gamble, P., Anderson, G. D., Hankins, G. D., et al. (2007a). Gender-specific effect of overexpression of sFlt-1 in pregnant mice on fetal programming of blood pressure in the offspring later in life. Am. J. Obstet. Gynecol. 197, 418.e1-e418.e5. doi: 10.1016/j.ajog.2007.06.064.
80. Lu, F., Longo, M., Tamayo, E., Maner, W., Al-Hendy, A., Anderson, G. D., et al. (2007b). The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am. J. Obstet. Gynecol. 196, 396.e1-396.e7; discussion 396.e397. doi: 10.1016/j.ajog.2006.12.024.
81. Lyall, F., Young, A., Boswell, F., Kingdom, J. C., and Greer, I. A. (1997). Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placenta 18, 269-276. doi: 10.1016/S0143-4004(97)80061-6.
82. MacLauchlan, S., Yu, J., Parrish, M., Asoulin, T. A., Schleicher, M., Krady, M. M., et al. (2011). Endothelial nitric oxide synthase controls the expression of the angiogenesis inhibitor thrombospondin 2. Proc. Natl. Acad. Sci. U.S.A. 108, E1137-E1145. doi: 10.1073/pnas.1104357108.
83. Maynard, S. E., Min, J. Y., Merchan, J., Lim, K. H., Li, J., Mondal, S., et al. (2003). Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111, 649-658. doi: 10.1172/JCI17189.
84. Merighi, S., Benini, A., Mirandola, P., Gessi, S., Varani, K., Simioni, C., et al. (2007). Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells. Mol. Pharmacol. 72, 395-406. doi: 10.1124/mol.106.032920.
85. Merighi, S., Simioni, C., Gessi, S., Varani, K., Mirandola, P., Tabrizi, M. A., et al. (2009). A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin. Neoplasia 11, 1064-1073..
86. Monga, R., Buck, S., Sharma, P., Thomas, R., and Chouthai, N. S. (2012). Effect of preeclampsia and intrauterine growth restriction on endothelial progenitor cells in human umbilical cord blood. J. Matern Fetal Neonatal. Med. 25, 2385-2389. doi: 10.3109/14767058.2012.697228.
87. Murfee, W. L., and Schmid-Schonbein, G. W. (2008). Chapter 12. Structure of microvascular networks in genetic hypertension. Methods Enzymol. 444, 271-284. doi: 10.1016/S0076-6879(08)02812-7.
88. Murphy, S. R., Lamarca, B., Cockrell, K., Arany, M., and Granger, J. P. (2012). L-Arginine supplementation abolishes the blood pressure and endothelin response to chronic increases in plasma sFlt-1 in pregnant rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 302, R259-R263. doi: 10.1152/ajpregu.00319.2011.
89. Noon, J. P., Walker, B. R., Webb, D. J., Shore, A. C., Holton, D. W., Edwards, H. V., et al. (1997). Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J. Clin. Invest. 99, 1873-1879. doi: 10.1172/JCI119354.
90. Oglaend, B., Forman, M. R., Romundstad, P. R., Nilsen, S. T., and Vatten, L. J. (2009). Blood pressure in early adolescence in the offspring of preeclamptic and normotensive pregnancies. J. Hypertens. 27, 2051-2054. doi: 10.1097/HJH.0b013e328330052a.
91. Olah, M. E., and Stiles, G. L. (2000). The role of receptor structure in determining adenosine receptor activity. Pharmacol. Ther. 85, 55-75. doi: 10.1016/S0163-7258(99)00051-0.
92. Ounsted, M., Cockburn, J., Moar, V. A., and Redman, C. W. (1983). Maternal hypertension with superimposed pre-eclampsia: effects on child development at 71/2 years. Br. J. Obstet. Gynaecol. 90, 644-649. doi: 10.1111/j.1471-0528.1983.tb09283.x.
93. Palmsten, K., Buka, S. L., and Michels, K. B. (2010). Maternal pregnancy-related hypertension and risk for hypertension in offspring later in life. Obstet. Gynecol. 116, 858-864. doi: 10.1097/AOG.0b013e3181f3a1f9.
94. Palti, H., and Rothschild, E. (1989). Blood pressure and growth at 6 years of age among offsprings of mothers with hypertension of pregnancy. Early Hum. Dev. 19, 263-269. doi: 10.1016/0378-3782(89)90061-3.
95. Pinhal-Enfield, G., Ramanathan, M., Hasko, G., Vogel, S. N., Salzman, A. L., Boons, G. J., et al. (2003). An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. Am. J. Pathol. 163, 711-721. doi: 10.1016/S0002-9440(10)63698-X.
96. Pladys, P., Sennlaub, F., Brault, S., Checchin, D., Lahaie, I., Le, N. L., et al. (2005). Microvascular rarefaction and decreased angiogenesis in rats with fetal programming of hypertension associated with exposure to a low-protein diet in utero. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289, R1580-R1588. doi: 10.1152/ajpregu.00031.2005.
97. Riano, A., Ortiz-Masia, D., Velazquez, M., Calatayud, S., Esplugues, J. V., and Barrachina, M. D. (2011). Nitric oxide induces HIF-1alpha stabilization and expression of intestinal trefoil factor in the damaged rat jejunum and modulates ulcer healing. J. Gastroenterol. 46, 565-576. doi: 10.1007/s00535-011-0374-1.
98. Risau, W. (1997). Mechanisms of angiogenesis. Nature 386, 671-674. doi: 10.1038/386671a0.
99. Roberts, J. M., and Escudero, C. (2012). The placenta in preeclampsia. Hypertens. Pregnancy 2, 72-83. doi: 10.1016/j.preghy.2012.01.001.
100. Roberts, J. M., Taylor, R. N., Musci, T. J., Rodgers, G. M., Hubel, C. A., and Mclaughlin, M. K. (1989). Preeclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol. 161, 1200-1204. doi: 10.1016/0002-9378(89)90665-0.
101. Rolland-Turner, M., Goretti, E., Bousquenaud, M., Leonard, F., Nicolas, C., Zhang, L., et al. (2013). Adenosine stimulates the migration of human endothelial progenitor cells. Role of CXCR4 and microRNA-150. PLoS ONE 8:e54135. doi: 10.1371/journal.pone.0054135.
102. Ryzhov, S., Biktasova, A., Goldstein, A. E., Zhang, Q., Biaggioni, I., Dikov, M. M., et al. (2014). Role of JunB in adenosine A2B receptor-mediated vascular endothelial growth factor production. Mol. Pharmacol. 85, 62-73. doi: 10.1124/mol.113.088567.
103. Ryzhov, S., Solenkova, N. V., Goldstein, A. E., Lamparter, M., Fleenor, T., Young, P. P., et al. (2008). Adenosine receptor-mediated adhesion of endothelial progenitors to cardiac microvascular endothelial cells. Circ. Res. 102, 356-363. doi: 10.1161/CIRCRESAHA.107.158147.
104. Saitoh, O., Saitoh, Y., and Nakata, H. (1994). Regulation of A2a adenosine receptor mRNA expression by agonists and forskolin in PC12 cells. Neuroreport 5, 1317-1320. doi: 10.1097/00001756-199406270-00005.
105. Schaddelee, M. P., Voorwinden, H. L., Van Tilburg, E. W., Pateman, T. J., Ijzerman, A. P., Danhof, M., et al. (2003). Functional role of adenosine receptor subtypes in the regulation of blood-brain barrier permeability: possible implications for the design of synthetic adenosine derivatives. Eur. J. Pharm. Sci. 19, 13-22. doi: 10.1016/S0928-0987(03)00034-4.
106. Schieke, S. M., Briviba, K., Klotz, L. O., and Sies, H. (1999). Activation pattern of mitogen-activated protein kinases elicited by peroxynitrite: attenuation by selenite supplementation. FEBS Lett. 448, 301-303. doi: 10.1016/S0014-5793(99)00372-5.
107. Seidman, D. S., Laor, A., Gale, R., Stevenson, D. K., Mashiach, S., and Danon, Y. L. (1991). Pre-eclampsia and offspring's blood pressure, cognitive ability and physical development at 17-years-of-age. Br. J. Obstet. Gynaecol. 98, 1009-1014. doi: 10.1111/j.1471-0528.1991.tb15339.x.
108. Shibuya, M. (2006). Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J. Biochem. Mol. Biol. 39, 469-478. doi: 10.5483/BMBRep.2006.39.5.469.
109. Shibuya, M. (2013). Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. J. Biochem. 153, 13-19. doi: 10.1093/jb/mvs136.
110. Sibai, B., Dekker, G., and Kupferminc, M. (2005). Pre-eclampsia. Lancet 365, 785-799. doi: 10.1016/S0140-6736(05)17987-2.
111. Sobrevia, L., Guzmán-Gutiérrez, E., Westermeier, F., Salomón, C., Arroyo, P., Palacios, E., et al. (2012). "Fetoplacental vascular pathophysiology in preeclampsia," in Recent Research Developments in Physiology, ed. L. Sobrevia (India: Research Signpost), 105-158.
112. Sobrevia, L., Nadal, A., Yudilevich, D. L., and Mann, G. E. (1996). Activation of L-arginine transport (system y+) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells. J. Physiol. 490(Pt 3), 775-781..
113. Spaans, F., Vos, P. D., Bakker, W. W., Van Goor, H., and Faas, M. M. (2014). Danger signals from ATP and adenosine in pregnancy and preeclampsia. Hypertension 63, 1154-1160. doi: 10.1161/HYPERTENSIONAHA.114.03240.
114. St. Hilaire, C., Carroll, S. H., Chen, H., and Ravid, K. (2009). Mechanisms of induction of adenosine receptor genes and its functional significance. J. Cell Physiol. 218, 35-44. doi: 10.1002/jcp.21579.
115. Staff, A. C., Braekke, K., Harsem, N. K., Lyberg, T., and Holthe, M. R. (2005). Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 122, 33-39. doi: 10.1016/j.ejogrb.2004.11.015.
116. Staff, A. C., Braekke, K., Johnsen, G. M., Karumanchi, S. A., and Harsem, N. K. (2007). Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia. Am. J. Obstet. Gynecol. 197, 176.e1-176.e6. doi: 10.1016/j.ajog.2007.03.036.
117. Stark, M. J., Clifton, V. L., and Wright, I. M. (2009). Neonates born to mothers with preeclampsia exhibit sex-specific alterations in microvascular function. Pediatr. Res. 65, 292-295. doi: 10.1203/PDR.0b013e318193edf1.
118. Swarup, J., Balkundi, D., Sobchak Brozanski, B., Roberts, J. M., and Yanowitz, T. D. (2005). Effect of preeclampsia on blood pressure in newborn very low birth weight infants. Hypertens. Pregnancy 24, 223-234. doi: 10.1080/10641950500281209.
119. Szymonowicz, W., and Yu, V. Y. (1987). Severe pre-eclampsia and infants of very low birth weight. Arch. Dis. Child. 62, 712-716. doi: 10.1136/adc.62.7.712.
120. Takagi, H., King, G. L., Robinson, G. S., Ferrara, N., and Aiello, L. P. (1996). Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Invest. Ophthalmol. Vis. Sci. 37, 2165-2176.
121. Tannetta, D. S., Dragovic, R. A., Gardiner, C., Redman, C. W., and Sargent, I. L. (2013). Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of flt-1 and endoglin. PLoS ONE 8:e56754. doi: 10.1371/journal.pone.0056754.
122. Tenhola, S., Rahiala, E., Halonen, P., Vanninen, E., and Voutilainen, R. (2006). Maternal preeclampsia predicts elevated blood pressure in 12-year-old children: evaluation by ambulatory blood pressure monitoring. Pediatr. Res. 59, 320-324. doi: 10.1203/01.pdr.0000196734.54473.e3.
123. Tenhola, S., Rahiala, E., Martikainen, A., Halonen, P., and Voutilainen, R. (2003). Blood pressure, serum lipids, fasting insulin, and adrenal hormones in 12-year-old children born with maternal preeclampsia. J. Clin. Endocrinol. Metab. 88, 1217-1222. doi: 10.1210/jc.2002-020903.
124. Thadhani, R., Kisner, T., Hagmann, H., Bossung, V., Noack, S., Schaarschmidt, W., et al. (2011). Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation 124, 940-950. doi: 10.1161/CIRCULATIONAHA.111.034793.
125. Tsao, P. N., Wei, S. C., Su, Y. N., Chou, H. C., Chen, C. Y., and Hsieh, W. S. (2005). Excess soluble fms-like tyrosine kinase 1 and low platelet counts in premature neonates of preeclamptic mothers. Pediatrics 116, 468-472. doi: 10.1542/peds.2004-2240.
126. Tuovinen, S., Raikkonen, K., Kajantie, E., Pesonen, A. K., Heinonen, K., Osmond, C., et al. (2010). Depressive symptoms in adulthood and intrauterine exposure to pre-eclampsia: the Helsinki Birth Cohort Study. BJOG 117, 1236-1242. doi: 10.1111/j.1471-0528.2010.02634.x.
127. Tuovinen, S., Raikkonen, K., Pesonen, A. K., Lahti, M., Heinonen, K., Wahlbeck, K., et al. (2012). Hypertensive disorders in pregnancy and risk of severe mental disorders in the offspring in adulthood: the Helsinki Birth Cohort Study. J. Psychiatr. Res. 46, 303-310. doi: 10.1016/j.jpsychires.2011.11.015.
128. Vatten, L. J., Romundstad, P. R., Holmen, T. L., Hsieh, C. C., Trichopoulos, D., and Stuver, S. O. (2003). Intrauterine exposure to preeclampsia and adolescent blood pressure, body size, and age at menarche in female offspring. Obstet. Gynecol. 101, 529-533. doi: 10.1016/S0029-7844(02)02718-7.
129. Villar, J., Carroli, G., Wojdyla, D., Abalos, E., Giordano, D., Ba'aqeel, H., et al. (2006). Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am. J. Obstet. Gynecol. 194, 921-931. doi: 10.1016/j.ajog.2005.10.813.
130. Von Versen-Hoynck, F., Rajakumar, A., Bainbridge, S. A., Gallaher, M. J., Roberts, J. M., and Powers, R. W. (2009). Human placental adenosine receptor expression is elevated in preeclampsia and hypoxia increases expression of the A2A receptor. Placenta 30, 434-442. doi: 10.1016/j.placenta.2009.02.004.
131. Wadsack, C., Desoye, G., and Hiden, U. (2012). The feto-placental endothelium in pregnancy pathologies. Wien. Med. Wochenschr. 162, 220-224. doi: 10.1007/s10354-012-0075-2.
132. Wu, C. S., Nohr, E. A., Bech, B. H., Vestergaard, M., Catov, J. M., and Olsen, J. (2009). Health of children born to mothers who had preeclampsia: a population-based cohort study. Am. J. Obstet. Gynecol. 201, 269.e1-269.e10. doi: 10.1016/j.ajog.2009.06.060.
133. Wu, C. S., Nohr, E. A., Bech, B. H., Vestergaard, M., Catov, J. M., and Olsen, J. (2011). Diseases in children born to mothers with preeclampsia: a population-based sibling cohort study. Am. J. Obstet. Gynecol. 204, 157.e1-157.e5. doi: 10.1016/j.ajog.2010.08.046.
134. Wyatt, A. W., Steinert, J. R., Wheeler-Jones, C. P., Morgan, A. J., Sugden, D., Pearson, J. D., et al. (2002). Early activation of the p42/p44MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism. FASEB J. 16, 1584-1594. doi: 10.1096/fj.01-0125com.
135. Xia, L., Zhou, X. P., Zhu, J. H., Xie, X. D., Zhang, H., Wang, X. X., et al. (2007). Decrease and dysfunction of endothelial progenitor cells in umbilical cord blood with maternal pre-eclampsia. J. Obstet. Gynaecol. Res. 33, 465-474. doi: 10.1111/j.1447-0756.2007.00555.x.
136. Xiong, X., Demianczuk, N. N., Saunders, L. D., Wang, F. L., and Fraser, W. D. (2002). Impact of preeclampsia and gestational hypertension on birth weight by gestational age. Am. J. Epidemiol. 155, 203-209. doi: 10.1093/aje/155.3.203.
137. Xu, M. H., Gong, Y. S., Su, M. S., Dai, Z. Y., Dai, S. S., Bao, S. Z., et al. (2011). Absence of the adenosine A2A receptor confers pulmonary arterial hypertension and increased pulmonary vascular remodeling in mice. J. Vasc. Res. 48, 171-183. doi: 10.1159/000316935.
138. Yoneyama, Y., Sawa, R., Suzuki, S., Otsubo, Y., Miura, A., Kuwabara, Y., et al. (2002a). Serum adenosine deaminase activity in women with pre-eclampsia. Gynecol. Obstet. Invest. 54, 164-167. doi: 10.1159/000067885.
139. Yoneyama, Y., Sawa, R., Suzuki, S., Shin, S., Power, G. G., and Araki, T. (1996). The relationship between uterine artery Doppler velocimetry and umbilical venous adenosine levels in pregnancies complicated by preeclampsia. Am. J. Obstet. Gynecol. 174, 267-271. doi: 10.1016/S0002-9378(96)70406-4.
140. Yoneyama, Y., Suzuki, S., Sawa, R., Kiyokawa, Y., Power, G. G., and Araki, T. (2001). Plasma adenosine levels and P-selectin expression on platelets in preeclampsia. Obstet. Gynecol. 97, 366-370. doi: 10.1016/S0029-7844(00)01184-4.
141. Yoneyama, Y., Suzuki, S., Sawa, R., Takeuchi, T., Kobayashi, H., Takei, R., et al. (2000). Changes in plasma adenosine concentrations during normal pregnancy. Gynecol. Obstet. Invest. 50, 145-148. doi: 10.1159/000010313.
142. Yoneyama, Y., Suzuki, S., Sawa, R., Yoneyama, K., Power, G. G., and Araki, T. (2002b). Increased plasma adenosine concentrations and the severity of preeclampsia. Obstet. Gynecol. 100, 1266-1270. doi: 10.1016/S0029-7844(02)02247-0.
143. Yoneyama, Y., Suzuki, S., Sawa, R., Yoneyama, K., Power, G. G., and Araki, T. (2002c). Relation between adenosine and T-helper 1/T-helper 2 imbalance in women with preeclampsia. Obstet. Gynecol. 99, 641-646. doi: 10.1016/S0029-7844(02)01657-5.
144. Yu, X. D., Branch, D. W., Karumanchi, S. A., and Zhang, J. (2012). Preeclampsia and retinopathy of prematurity in preterm births. Pediatrics 130, e101-e107. doi: 10.1542/peds.2011-3881